| abstract |
The present invention provides glycan-interacting antibodies, methods of producing glycan-interacting antibodies useful in the treatment and prevention of human diseases including cancer. Such glycan interacting antibodies include humanized antibodies, derivatives and fragments thereof, and related compositions and kits. Included are methods of using glycan interacting antibodies for treatment and diagnosis. |